Osaka and Tokyo, October 10, 2024 – Kansai Medical University Dr. Koichiro Higasa, (Professor, Department of Genome Analysis, Director, Institute of Biomedical Science) and Genesis Healthcare Co., Michel Mommejat (Chief Innovation Officer, A.D.A.M Innovation Center) are pleased to announce the first joint research collaboration in Japan, integrating Genomic Big Data held by both institutions and applying A.I. to accelerate new genomic discoveries across a diseases pertaining to psychiatric, immune, cardiovascular and respiratory diseases.
Genomic data and A.I. driving discovery
In this joint research, Genesis Healthcare’s GenesisGaia will serve as the A.I. platform foundation. GenesisGaia is one of the largest commercial genetic databases in Japan, with over 400,000 samples enriched with phenotypic data that will be applied to genomic data held by Kansai Medical University for A.I. applications utilizing cutting-edge cloud computing solutions.
This joint collaborative research will analyze genotyping, whole-genome sequences, and medical data sets, focusing on a range of targeted genetic diseases that stand to benefit from genomic discoveries and A.I. applications.
Through advancements in A.I. and the use of GenesisGaia, our joint research seeks to propel genetic research towards personalized medicine, making meaningful contributions to society as a whole, while maintaining the utmost privacy and security in the handling of genetic data.
For press and media inquiries, please contact:
Email: press@genesis-healthcare.jp
About Kansai Medical University
Kansai Medical University (KMU) is a leading private medical institution based in Osaka, Japan, dedicated to advancing healthcare through excellence in education, research, and clinical practice. Established in 1928, KMU offers comprehensive medical education and training, preparing future physicians and healthcare professionals with a strong foundation in both traditional and cutting-edge medical science. The university's affiliated teaching hospitals provide high-quality patient care and are renowned for their expertise in areas such as surgery, oncology, and internal medicine. With a strong commitment to research in fields like genomics, regenerative medicine, and public health, KMU fosters innovation and international collaboration to address global healthcare challenges. Kansai Medical University is deeply committed to community health and remains at the forefront of improving healthcare outcomes regionally and internationally.
For additional information, please visit:
About Genesis Healthcare Co.
Genesis Healthcare Co. is Japan’s leading genetic testing and research company, servicing medical institutions, corporations, and individuals to benefit from personalized health and precision medicine. Through its patented A.I. driven prediction models, Genesis Healthcare Co. provides advanced genetic testing services, from prevention to diagnostics.
For additional information, please visit:
GenesisGaia is a registered trademark of Genesis Healthcare Co.
Commentaires